Dilanubicel
- Generic Name
- Dilanubicel
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Phase 2
Terminated
- Conditions
- Acute Megakaryoblastic LeukemiaAcute Myeloid LeukemiaHematopoietic and Lymphoid Cell NeoplasmHIV InfectionAcute Erythroid LeukemiaMyelodysplastic Syndrome With Excess BlastsNon-Hodgkin LymphomaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveMyelodysplastic Syndrome
- Interventions
- Radiation: Total-Body IrradiationProcedure: Umbilical Cord Blood Transplantation
- First Posted Date
- 2019-09-10
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 1
- Registration Number
- NCT04083170
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
πΊπΈCleveland Cord Blood Center, Cleveland, Ohio, United States
πΊπΈUniversity of California San Francisco, San Francisco, California, United States
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Phase 2
Recruiting
- Conditions
- Acute Biphenotypic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell NeoplasmAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome With Excess Blasts
- Interventions
- Radiation: Total-Body IrradiationProcedure: Umbilical Cord Blood TransplantationOther: Laboratory Biomarker AnalysisProcedure: Biospecimen CollectionProcedure: Bone Marrow AspirateProcedure: Bone Marrow BiopsyProcedure: Multigated Acquisition ScanProcedure: ElectrocardiographyProcedure: Computed Tomography
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT03399773
- Locations
- πΊπΈ
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath